36.8K
Downloads
102
Episodes
Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry. Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.
Episodes
Tuesday Aug 03, 2021
Tuesday Aug 03, 2021
How do comorbidities affect patients with chronic spontaneous urticaria and what can be done to minimise their impact? Find out more on this crucial, yet understudied topic from our latest guest, Dr Simon Francis Thomsen.
Tuesday Jul 20, 2021
Tuesday Jul 20, 2021
In this episode, our host is joined by Dr Moshe Ben-Shoshan, who shares his pioneering approach to treating paediatric patients and draws on his experience to debunk some of the common myths surrounding childhood urticaria.
Tuesday Jul 06, 2021
Tuesday Jul 06, 2021
In this episode, our host is joined by UK-based dermatologist Dr Clive Grattan to address some of the most important unanswered questions in the field of chronic spontaneous urticaria.
Tuesday Jun 22, 2021
Tuesday Jun 22, 2021
In this very special episode, our host meets Cassandra, a patient who has been affected by CSU for many years. Listen now for unmissable insights into the patient experience and to find out more about what you do to better support your own patients in the future.
Tuesday Jun 08, 2021
Tuesday Jun 08, 2021
Did you know 12-20% of the population will experience acute urticaria sometime in their lifetime? In this episode, Dr Angèle Soria explains the differences between acute urticaria and other urticarias, how to manage the condition and what to look out for and highlights her most recent publication.
Tuesday May 25, 2021
Tuesday May 25, 2021
Did you know that not all patients with CSU develop wheals? In this episode, Professor Connie Katelaris explains the unique challenges physicians face when diagnosing and managing CSU patients who have pure angioedema without wheals, and offers advice on how to spot pseudoangioedema.
Wednesday May 12, 2021
Wednesday May 12, 2021
For those just starting out on their UCARE journey, the extensive list of criteria can seem daunting. In this episode, our host is joined by Professor Kanokvalai Kulthanan, who offers her advice on tackling the application process.
Tuesday Mar 16, 2021
Tuesday Mar 16, 2021
Since its inception in 2018, COLD-CE has collected data on hundreds of patients with cold urticaria from around the world. In this episode, Dr Mojca Bizjak reflects on her experience of running a UCARE project, offering insight and advice for those hoping to do so in the future.
Tuesday Mar 02, 2021
Tuesday Mar 02, 2021
Despite affecting up to 5% of the population, symptomatic dermographism remains understudied. Discover more about how our ability to diagnose and treat this common and debilitating condition is improving from urticaria expert, Dr Tomasz Hawro.
Tuesday Feb 16, 2021
Tuesday Feb 16, 2021
Dr Frank Siebenhaar brings us up to date on the differences between mastocytosis, urticaria and mast cell activation syndrome (MCAS). He also introduces CSUplus, an ongoing UCARE project that aims to shed light on the extracutaneous symptoms of chronic spontaneous urticaria.